"We are always seeking new ways to innovate and improve access to cutting-edge diagnostics for our patients so we can help them better manage their health conditions, including diabetes, which impacts nearly 66,000 OSF patients," Mark Meeker, DO, vice president of community medicine for OSF HealthCare, says in a press release.
That's why the Illinois-based health system has expanded the use of an artificial intelligence test that uses images of the retina to detect diabetic retinopathy, the leading cause of blindness for adults in the US, to 24 additional sites.
LumineticsCore is an FDA-cleared, autonomous AI platform that analyzes retinal images for signs of disease without the need for a specialist to interpret the images, per a press release.
With LumineticsCore, OSF has been able to inform 25% of nearly 1,500 patients with diabetes that they tested positive for diabetic retinopathy, per the press release.
Without convenient access to the exam, many of those patients might not have been tested for DR, the leading cause of blindness for adults in the US.
"The positive impact our partnership with OSF HealthCare is having in the lives of patients is exactly in line with our mission," says Sean Murnane, senior vice president of commercial for Digital Diagnostics, which Read the Entire Article
A customized collection of grant news from foundations and the federal government from around the Web.
Facebook announces a new feature called Donate which makes it possible for anybody to give back to a charity of their choice through its Facebook Page.